Applied DNA Sciences, Inc.
APDN
$5.37
-$0.14-2.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 26.09% | -138.84% | 8.23% | 160.64% | -859.90% |
| Total Depreciation and Amortization | -36.29% | -80.40% | -76.65% | -61.56% | -45.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -107.30% | 90.05% | 188.96% | -836.93% | 134.45% |
| Change in Net Operating Assets | 151.48% | 18.18% | -125.23% | -151.19% | -98.68% |
| Cash from Operations | 0.78% | 11.49% | -21.24% | -155.24% | -1,597.20% |
| Capital Expenditure | -1,152.03% | -- | 59.85% | 86.53% | 72.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,152.03% | -- | 59.85% | 86.53% | 72.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -69.36% | 13,729.39% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -70.18% | 18,066.38% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,080.09% | 175.49% | -11.28% | 576.32% | -230.88% |